Effects of N-acetylcysteine on radiocontrast nephropathy in rats

Scandinavian Journal of Urology and Nephrology

Volumn 40, Issue 1, 2006, Pages 63-69

  Yenicerioglu, Yavuz ^a,b   Yilmaz, Osman ^a   Sarioglu, Sulen ^a   Ormen, Murat ^a   Akan, Pinar ^a   Celik, Ali ^a   Camsari, Taner ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Contrast; N acetylcysteine; Nephropathy; Nephrotoxicity; Radiocontrast; Rat

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; EOSIN; HEMATOXYLIN; MALONALDEHYDE; SCHIFF BASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUSH BORDER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY NECROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE; MICROSCOPY; MORBIDITY; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RADIOCONTRAST NEPHROPATHY; RAT; RENAL PROTECTION; WATER DEPRIVATION;

ACETYLCYSTEINE; ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; GLOMERULAR FILTRATION RATE; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; KIDNEY TUBULES; PROBABILITY; RADIOPHARMACEUTICALS; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 32144458041     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590500329445     Document Type: Article

References (45)

1. Thompson JR, Henrich WL. Radiocontrast agent induced acute renal failure. In: Jacobson HR, Striker GE, Klahr S, editors. The principles and practice of nephrology, 2nd ed. St Louis, MO: Mosby Year Book Inc; 1995. p. 791-2.
2. Cohan RH, Dunnick NR. Intravascular contrast media: adverse reactions. AJR Am J Roentgenol 1987;149:665-70.
3. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 1987;83:65-71.
4. Weisberg LS, Kurnik PB, Kurnik BRC. Radiocontrast induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992;41:1408-15.
5. Porte G. Contrast associated nephropathy: presentation, pathophysiology and management. Miner Electrolyte Metab 1994;20:232-43.
6. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC. Radiocontrast medium induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990;258:F115-20.
7. Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media induced renal injury in volume depletion. Kidney Int 1992;41:1008-15.
8. Morcos SK, Thomsen HS, Web JA, and members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast medium induced nephrotoxicity: a consensus report. Eur Radiol 1999;9:1602-13.
9. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177-82.
10. Shammas NW, Kapalis MJ, Harris M, McKinney D, Coyne EP. Aminophylline does not protect against radiocontrast nephropathy in patients undergoing angiographic procedures. J Invest Cardiol 2001;13:738-40.
11. Neumayer HH, Junge E, Kufner A, Wenning A. Prevention of radiocontrast media induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized controlled trial. Nephrol Dial Transplant 1989;4:1030-6.
12. Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Muller C, Osswald H, Risler T. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999;14:1146-9.
13. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-80.
14. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
15. 1 study group. Nephrol Dial Transplant 2000;15:43-9.
16. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnich MR, et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000;57:1675-80.
17. Tepel M, Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic contrast agent induced reductions in renal function by N-acetylcysteine. N Engl J Med 2000;343:180-4.
18. Diaz-Sandoval LJ, Kosowsy BD, Losordo DW. Acetylcysteine to prevent angiography related renal tissue injury (The APART Trial). Am J Cardiol 2002;89:356-8.
19. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002;40:1383-8.
20. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002;40:298-303.
21. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003;289:553-8.
22. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 2003;41:2114-8.
23. Tadros GM, Mouhayar EN, Akinwande AO, Campbell B, Wood C, Blankenship JA. Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography. J Invasive Cardiol 2003;15:311-4.
24. Vallero A, Cesano G, Pozzato M, Garbo R, Minelli M, Quarello F, et al. Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC). G Ital Nefrol 2002;19:529-33.
25. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002;57:279-83.
26. Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002;62:2202-7.
27. Boccalandro F, Amhad M, Smalling RW, Sdringola S. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv 2003;58:336-41.
28. Draper HH, Hadley M. Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol 1990;186:421-31.
29. Kelly GS. Clinical applications of N-acetylcysteine. Altern Med Rev 1998;3:114-27.
30. Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S. Effect of N-acetylcysteine on gentamicin mediated nephropathy in rats. Eur J Pharmacol 2001;13:75-83.
31. Tariq M, Morais C, Sobki S, Sulaiman MA, Khader AA. N-acetylcysteine attenuates cyclosporine induced nephrotoxicity in rats. Nephrol Dial Transplant 1999;14:923-9.
32. Shaikh ZA, Zaman K, Tang W, Vu T. Treatment of cadmium nephrotoxicity by N-acetylcysteine. Toxicol Lett 1999;104:137-42.
33. Holt S, Goodier D, Marley R, Patch D, Burroughs A, Fernando B, et al. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 1999;353:294-5.
34. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol 2000;278:F1-12.
35. Vari RC, Natarajan LA, Whitescarver SA, Jackson BA, Ott CE. Induction, prevention and mechanisms of contrast medium induced acute renal failure. Kidney Int 1988;33:699-707.
36. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast induced renal artery constriction. Kidney Int 1993;44:1217-23.
37. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast media associated nephrotoxicity and atheroembolism. A critical review. Am J Kidney Dis 1994;24:713-27.
38. El Sayed AA, Haylor JL, El Nahas Am, Solzano S, Morcos SK. Haemodynamic effects of water soluble contrast media on the isolated perfused rat kidney. Br J Radiol 1991;64:435-9.
39. Haylor JL, El Sayed AA, El Nahas AM, Morcos SK. The effect of sodium iothalamate on the vascular resistance of the isolated perfused rat kidney. Br J Radiol 1991;64:50-4.
40. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997;29:465-77.
41. Salom MG, Ramirez P, Carbonell LF, Conesa EL, Cartagena J, Quesada T, Porilla P, Fenoy FJ. Protective effect of N-acetylcysteine on the renal failure induced by inferior vena cava occlusion. Transplantation 1998;65:1315-21.
42. Conesa EP, Valero F, Nadal JC, Fenoy FJ, Pez BL, Arregui BA, et al. N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 2001;281:R730-7.
43. Andrews NP, Prasad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001;37:117-23.
44. Lopez BL, Snyder JW, Birenbaum DS, Ma XI. N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery. Ann Emerg Med 1998;32:405-10.
45. Emch TM, Haller NA. A randomized trial of prophylactic acetylcysteine and theophylline compared with placebo for the prevention of renal tubular vacuolization in rats after iohexol administration. Acad Radiol 2003;10:514-9.